e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pulmonary venous thromboembolic disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of the clinical probability scores and diagnostic tests of deep venous thrombosis and pulmonary embolism
I. Porfyridis, G. Stathopoulos, A. Tsimogianni, I. Nikoloutsou, K. Stavrakaki, C. Roussos, N. Rovina (Athens, Greece)
Source:
Annual Congress 2008 - Pulmonary venous thromboembolic disease
Session:
Pulmonary venous thromboembolic disease
Session type:
Thematic Poster Session
Number:
1047
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Porfyridis, G. Stathopoulos, A. Tsimogianni, I. Nikoloutsou, K. Stavrakaki, C. Roussos, N. Rovina (Athens, Greece). Comparison of the clinical probability scores and diagnostic tests of deep venous thrombosis and pulmonary embolism. Eur Respir J 2008; 32: Suppl. 52, 1047
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Clinical significance of deep venous thrombosis in symptomatic pulmonary embolism
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
Does anatomic location of deep venous thrombosis affect the clinical findings and course in the patient of pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Prognostic significance of asymptomatic pulmonary embolism in patients with deep vein thrombosis
Source: Eur Respir J 2004; 24: Suppl. 48, 685s
Year: 2004
Comparison of three clinical scoring methods in patients with pulmonary thromboembolism
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006
Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012
Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
The comparison of three different clinical probability methods and the ECG score in patients with suspected venous thromboembolism
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Comparison of three clinical prediction rules among patients with suspected pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 685s
Year: 2004
Prediction of the severity of pulmonary embolism according to clinical pre-test and D-dimer concentration
Source: Eur Respir J 2006; 28: Suppl. 50, 402s
Year: 2006
Risk of deep vein thrombosis and pulmonary embolism in asthma
Source: Eur Respir J 2013; 42: 655-661
Year: 2013
Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003
Empirical assessment of clinical suspicion in the diagnosis of deep venous thombosis
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002
Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Clinical probability and d-dimer utility in the context of suspected pulmonary embolism: The safe approach
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Evaluation of various procedures in the diagnosis of pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
D-dimer is of limited value in the diagnosis of pulmonary embolism
Source: Eur Respir J 2003; 22: Suppl. 45, 218s
Year: 2003
Associations of probability scores in pulmonary embolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Comparation between micro-elisa and latex aglutination methods for determination of concentration of D-dimer at patients with venous thrombosis and pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 25s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept